Skip to main content
Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.510
-0.050 (-1.40%)
At close: Apr 28, 2026, 4:00 PM EDT
3.530
+0.020 (0.57%)
After-hours: Apr 28, 2026, 4:00 PM EDT

Adagene Revenue

In the year 2025, Adagene had annual revenue of $7.67M with 7,332.76% growth. Adagene had revenue of $7.67M in the half year ending December 31, 2025, with 840.35% growth.

Revenue (ttm)
$7.67M
Revenue Growth
+7,332.76%
P/S Ratio
31.18
Revenue / Employee
$59,929
Employees
128
Market Cap
231.91M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20257.67M7.57M7,332.76%
Dec 31, 2024103.20K-18.01M-99.43%
Dec 31, 202318.11M8.82M94.90%
Dec 31, 20229.29M-882.53K-8.67%
Dec 31, 202110.18M9.47M1,351.71%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Arcturus Therapeutics Holdings 82.03M
Codexis 70.39M
Fennec Pharmaceuticals 44.64M
Orchestra BioMed Holdings 33.48M
Sol-Gel Technologies 19.39M
Camp4 Therapeutics 3.50M
Milestone Pharmaceuticals 1.55M
Artiva Biotherapeutics 251.00K
Revenue Rankings

ADAG News

More News